tiprankstipranks
Trending News
More News >
NovaBridge Biosciences (NBP)
NASDAQ:NBP
US Market

NovaBridge Biosciences (NBP) Ratios

Compare
423 Followers

NovaBridge Biosciences Ratios

NBP's free cash flow for Q3 2025 was ¥0.00. For the 2025 fiscal year, NBP's free cash flow was decreased by ¥ and operating cash flow was ¥0.00. See a summary of the company’s cash flow.
Ratios
TTM
Dec 24Dec 23Dec 22Dec 21
Liquidity Ratios
Current Ratio
14.47 5.67 5.50 7.66 9.28
Quick Ratio
14.47 5.60 5.62 7.62 10.01
Cash Ratio
14.17 0.73 4.87 5.65 8.26
Solvency Ratio
-1.32 -1.61 -2.33 -2.23 0.68
Operating Cash Flow Ratio
0.11 -0.18 -1.67 -1.56 0.75
Short-Term Operating Cash Flow Coverage
0.00 -17.19 -58.18 0.00 -12.46
Net Current Asset Value
¥ 214.28M¥ 1.44B¥ 2.56B¥ 3.74B¥ 4.64B
Leverage Ratios
Debt-to-Assets Ratio
0.01 <0.01 0.02 0.02 <0.01
Debt-to-Equity Ratio
0.01 0.01 0.02 0.02 <0.01
Debt-to-Capital Ratio
0.01 0.01 0.02 0.02 <0.01
Long-Term Debt-to-Capital Ratio
0.00 0.00 0.00 0.02 0.00
Financial Leverage Ratio
1.07 1.52 1.35 1.23 1.13
Debt Service Coverage Ratio
0.00 10.82 -102.59 0.00 -4.50
Interest Coverage Ratio
0.00 -12.14K -1.51M 0.00 1.06K
Debt to Market Cap
0.00 <0.01 <0.01 <0.01 >-0.01
Interest Debt Per Share
0.03 0.10 0.40 0.64 0.09
Net Debt to EBITDA
6.76 0.23 1.61 1.66 -28.19
Profitability Margins
Gross Profit Margin
0.00%100.00%112.29%47.25%100.00%
EBIT Margin
0.00%-747.60%163.98%-416.10%10.08%
EBITDA Margin
0.00%-4384.57%877.46%-2337.41%10.91%
Operating Profit Margin
0.00%-4471.20%888.90%-2353.06%10.08%
Pretax Profit Margin
0.00%-5302.03%1131.34%-2652.28%31.32%
Net Profit Margin
0.00%-5302.03%1131.65%-2648.70%30.53%
Continuous Operations Profit Margin
0.00%-747.97%1131.65%-415.54%30.53%
Net Income Per EBT
93.23%100.00%100.03%99.86%97.47%
EBT Per EBIT
75.78%118.58%127.27%112.72%310.57%
Return on Assets (ROA)
-8.85%-56.09%-61.55%-41.42%7.43%
Return on Equity (ROE)
-11.48%-85.31%-83.35%-50.82%8.37%
Return on Capital Employed (ROCE)
-13.29%-56.15%-57.69%-41.38%2.70%
Return on Invested Capital (ROIC)
-13.25%-7.90%-57.33%-41.18%2.65%
Return on Tangible Assets
-8.85%-56.45%-66.12%-43.60%7.78%
Earnings Yield
-5.40%-130.65%-45.82%-4.43%0.98%
Efficiency Ratios
Receivables Turnover
0.00 15.08 -46.05 0.31 11.82
Payables Turnover
0.00 0.00 0.00 0.00 0.00
Inventory Turnover
0.00 0.00 -0.34 1.70 0.00
Fixed Asset Turnover
0.00 4.98 -1.79 0.56 38.31
Asset Turnover
0.00 0.01 -0.05 0.02 0.24
Working Capital Turnover Ratio
0.00 0.01 -0.06 0.02 0.56
Cash Conversion Cycle
0.00 24.20 -1.08K 1.40K 30.88
Days of Sales Outstanding
0.00 24.20 -7.93 1.19K 30.88
Days of Inventory Outstanding
0.00 0.00 -1.08K 214.11 0.00
Days of Payables Outstanding
0.00 0.00 0.00 0.00 0.00
Operating Cycle
0.00 24.20 -1.08K 1.40K 30.88
Cash Flow Ratios
Operating Cash Flow Per Share
0.02 -0.38 -5.81 -5.57 2.76
Free Cash Flow Per Share
0.02 -0.38 -6.05 -5.74 2.71
CapEx Per Share
<0.01 0.06 0.24 0.17 0.05
Free Cash Flow to Operating Cash Flow
1.00 1.00 1.04 1.03 0.98
Dividend Paid and CapEx Coverage Ratio
322.12K -6.40 -24.06 -32.51 54.14
Capital Expenditure Coverage Ratio
322.12K -6.40 -24.06 -32.51 54.14
Operating Cash Flow Coverage Ratio
0.56 -3.85 -14.71 -8.65 31.88
Operating Cash Flow to Sales Ratio
0.00 -2.63 4.98 -11.05 0.28
Free Cash Flow Yield
0.36%-2.82%-20.99%-1.91%0.88%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
-18.51 -0.77 -2.18 -22.55 102.55
Price-to-Sales (P/S) Ratio
0.00 40.58 -24.70 597.25 31.30
Price-to-Book (P/B) Ratio
1.75 0.65 1.82 11.46 8.58
Price-to-Free Cash Flow (P/FCF) Ratio
280.92 -15.40 -4.76 -52.41 113.48
Price-to-Operating Cash Flow Ratio
246.04 -15.43 -4.96 -54.03 111.39
Price-to-Earnings Growth (PEG) Ratio
-0.72 0.02 2.16 0.05 -0.78
Price-to-Fair Value
1.75 0.65 1.82 11.46 8.58
Enterprise Value Multiple
-8.84 -0.69 -1.20 -23.89 258.73
Enterprise Value
293.91M 2.30B 2.33B 49.16B 43.55B
EV to EBITDA
-8.84 -1.90 -1.20 -23.89 258.73
EV to Sales
0.00 83.09 -10.53 558.50 28.23
EV to Free Cash Flow
159.18 -31.53 -2.03 -49.01 102.33
EV to Operating Cash Flow
159.18 -31.60 -2.12 -50.52 100.44
Tangible Book Value Per Share
2.56 8.89 14.37 24.65 34.05
Shareholders’ Equity Per Share
2.56 8.98 15.85 26.27 35.85
Tax and Other Ratios
Effective Tax Rate
0.00 0.86 >-0.01 >-0.01 0.03
Revenue Per Share
0.00 0.14 -1.17 0.50 9.83
Net Income Per Share
-0.24 -7.66 -13.21 -13.35 3.00
Tax Burden
0.93 1.00 1.00 1.00 0.97
Interest Burden
0.79 7.09 6.90 6.37 3.11
Research & Development to Revenue
0.00 4.14 -4.08 13.78 0.64
SG&A to Revenue
0.00 2.31 -3.68 10.22 0.26
Stock-Based Compensation to Revenue
0.00 6.98 -1.61 6.91 0.32
Income Quality
-0.02 0.35 0.44 0.42 0.92
Currency in CNY